首页 | 本学科首页   官方微博 | 高级检索  
     

原发性肝癌肝动脉热化疗栓塞后患者T 细胞亚群及sIL-2R 的改变
引用本文:齐连君,王执民,郭卫平,倪代会. 原发性肝癌肝动脉热化疗栓塞后患者T 细胞亚群及sIL-2R 的改变[J]. 肿瘤防治研究, 2001, 28(1): 39-40
作者姓名:齐连君  王执民  郭卫平  倪代会
作者单位:710038 西安,第四军医大学唐都医院介入放射科
摘    要: 目的 研究肝癌患者肝动脉热化疗栓塞前后 T细胞亚群及 s IL - 2 R的变化及其临床意义。方法 采用免疫荧光染色法及双抗体夹心法 ,检测 30例原发性肝癌患者治疗前后的 T细胞亚群及 s IL- 2 R的改变 ,并与健康对照组比较分析。结果 肝癌组治疗前 Th降低 ,Ts和 s IL- 2 R增高 ,与对照组比较有显著差异 ,P<0 .0 1 ,治疗后 Th升高 ,Ts和 s IL- 2 R降低 ,治疗前后比较有显著差异 P<0 .0 1。结论 检测肝癌患者 T细胞亚群 ,s IL- 2 R的情况 ,有助了解病人的免疫状况 ,对判断病人预后 ,指导综合治疗有一定价值。热化疗栓塞的疗效优于文献报道的单纯化疗栓塞。

关 键 词:原发性肝癌  热化疗栓塞  T 细胞亚群  白介素 2 受体
文章编号:1000-8578(2001)01-0039-02
收稿时间:2000-02-23
修稿时间:2000-02-23

Changes of SolubleInterleukin 2 Receptor and T Lymphocytes Subsets in Patients with PHC afterThermochemoembolotherapy
QI Lian|jun,WANG Zhi|min,GUO Wei|ping,et al Tangdu Hospital,Fouth Military University,Xi'an ,China$$$$. Changes of SolubleInterleukin 2 Receptor and T Lymphocytes Subsets in Patients with PHC afterThermochemoembolotherapy[J]. Cancer Research on Prevention and Treatment, 2001, 28(1): 39-40
Authors:QI Lian|jun  WANG Zhi|min  GUO Wei|ping  et al Tangdu Hospital  Fouth Military University  Xi'an   China$$$$
Affiliation:QI Lian|jun,WANG Zhi|min,GUO Wei|ping,et al Tangdu Hospital,Fouth Military University,Xi'an 710038,China$$$$
Abstract:Objective To observe the changes of sIL|2R and T lymphocytes subsets in patients with PHC before and after thermochemoembolotherapy and evaluate their clinical significance.Methods Immune fluorescent assay and sandwich ELISA were used to measure the immune state of 30 patients with PHC before and after thermochemoembolotherapy and compared them with that of health comtrols.Results In patients with PHC,Th was lower while Ts and sIL|2R were higher than that of health controls (P< 0.01 ).After therapy,Th elevated while Ts and sIL|2R declined(P<0.01).Conclusion Measuring sIL|2R and T lymphocytes subsets is helpful to know the immune state and has significance in directing therapy and judging prognosis.To patients with PHC,the method of thermochemoembolotherapy is superior to that of simplex chemoembolotherapy from medical document.
Keywords:Primary Hepatic Cancer(PHC)  Thermochemoembolotherapy  Soluble interleukin 2 receptor(sIL|2R)  T Lymphocyte subset
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号